Caroline A. Bray

848 total citations
18 papers, 607 citations indexed

About

Caroline A. Bray is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Caroline A. Bray has authored 18 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Caroline A. Bray's work include Cutaneous Melanoma Detection and Management (6 papers), Renal cell carcinoma treatment (4 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Caroline A. Bray is often cited by papers focused on Cutaneous Melanoma Detection and Management (6 papers), Renal cell carcinoma treatment (4 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Caroline A. Bray collaborates with scholars based in United Kingdom, Australia and Norway. Caroline A. Bray's co-authors include Rona M. MacKie, David Hole, M. Nicolson, Alan Evans, R.M. MACKIE, Arthur Morris, Valerie Doherty, David R. Thomson, J.P. VESTEY and V.R. Doherty and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and British Journal of Cancer.

In The Last Decade

Caroline A. Bray

18 papers receiving 583 citations

Peers

Caroline A. Bray
V. Oliver Spain
Bridie S. Thompson Australia
Giovanni Lo Scocco Italy
Amy R. Quillo United States
F. Haddad United States
Martha Matsumoto United States
Ludger Barthelmes United Kingdom
Stephen Calabro United States
M Cavaillé‐Coll United States
M. M. Oken United States
V. Oliver Spain
Caroline A. Bray
Citations per year, relative to Caroline A. Bray Caroline A. Bray (= 1×) peers V. Oliver

Countries citing papers authored by Caroline A. Bray

Since Specialization
Citations

This map shows the geographic impact of Caroline A. Bray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline A. Bray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline A. Bray more than expected).

Fields of papers citing papers by Caroline A. Bray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline A. Bray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline A. Bray. The network helps show where Caroline A. Bray may publish in the future.

Co-authorship network of co-authors of Caroline A. Bray

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline A. Bray. A scholar is included among the top collaborators of Caroline A. Bray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline A. Bray. Caroline A. Bray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Papadopoulos, Kyriakos P., Afshin Dowlati, Juanita Lopez, et al.. (2024). 650P Initial results from a phase I/II study of BT7480, a novel nectin-4/CD137 bicycle tumor-targeted immune cell agonist, in patients (pts) with advanced solid tumors. Annals of Oncology. 35. S513–S514. 1 indexed citations
2.
Powles, Thomas, Syed A. Hussain, Andrew Protheroe, et al.. (2016). PLUTO: A randomised phase II study of pazopanib versus paclitaxel in relapsed urothelial tumours.. Journal of Clinical Oncology. 34(2_suppl). 430–430. 5 indexed citations
3.
MacLeod, Nicholas, Anthony J. Chalmers, N. O’Rourke, et al.. (2015). Is Radiotherapy Useful for Treating Pain in Mesothelioma?: A Phase II Trial. Journal of Thoracic Oncology. 10(6). 944–950. 50 indexed citations
4.
Macpherson, Iain R., Caroline A. Bray, C. A. Hopkins, et al.. (2014). Loading Dose Ibandronate Versus Standard Oral Ibandronate in Patients With Bone Metastases From Breast Cancer. Clinical Breast Cancer. 15(2). 117–127. 4 indexed citations
5.
6.
Partridge, Mike, Marie Fallon, Caroline A. Bray, et al.. (2012). Prognostication in Advanced Cancer: A Study Examining an Inflammation-Based Score. Journal of Pain and Symptom Management. 44(2). 161–167. 27 indexed citations
7.
Aitchison, Michael, Caroline A. Bray, Hendrik Van Poppel, et al.. (2011). Final results from an EORTC (GU Group)/NCRI randomized phase III trial of adjuvant interleukin-2, interferon alpha, and 5-fluorouracil in patients with a high risk of relapse after nephrectomy for renal cell carcinoma (RCC).. Journal of Clinical Oncology. 29(15_suppl). 4505–4505. 8 indexed citations
8.
Robertson, Gerry, Nicola Greenlaw, Caroline A. Bray, & David Morrison. (2010). Explaining the effects of socio-economic deprivation on survival in a national prospective cohort study of 1909 patients with head and neck cancers. Cancer Epidemiology. 34(6). 682–688. 20 indexed citations
9.
Bray, Caroline A., David Morrison, & Pam McKay. (2008). Socio-economic deprivation and survival of non-Hodgkin lymphoma in Scotland. Leukemia & lymphoma. 49(5). 917–923. 12 indexed citations
10.
Whiteman, David C., Caroline A. Bray, Victor Siskind, et al.. (2008). Changes in the incidence of cutaneous melanoma in the west of Scotland and Queensland, Australia: hope for health promotion?. European Journal of Cancer Prevention. 17(3). 243–250. 36 indexed citations
11.
Aitchison, Michael, Caroline A. Bray, Hendrik Van Poppel, et al.. (2008). Preliminary results from a randomized phase III trial of adjuvant interleukin-2, interferon alpha and 5-fluorouracil in patients with a high risk of relapse after nephrectomy for renal cell carcinoma (RCC). Journal of Clinical Oncology. 26(15_suppl). 5040–5040. 4 indexed citations
12.
MACKIE, R.M., Caroline A. Bray, J.P. VESTEY, et al.. (2007). Melanoma incidence and mortality in Scotland 1979–2003. British Journal of Cancer. 96(11). 1772–1777. 86 indexed citations
13.
Whiteman, David C., Caroline A. Bray, Victor Siskind, et al.. (2007). A comparison of the anatomic distribution of cutaneous melanoma in two populations with different levels of sunlight: the west of Scotland and Queensland, Australia 1982–2001. Cancer Causes & Control. 18(5). 485–491. 21 indexed citations
14.
Bray, Caroline A., et al.. (2006). Value of sentinel node status as a prognostic factor in melanoma: prospective observational study. BMJ. 332(7555). 1423–1423. 42 indexed citations
15.
Broom, J., Jenny Brown, Rachel Laws, et al.. (2005). The impact of obesity on drug prescribing in primary care. British Journal of General Practice. 55(519). 743–749. 53 indexed citations
16.
MACKIE, R.M. & Caroline A. Bray. (2004). Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma. British Journal of Cancer. 90(4). 770–772. 31 indexed citations
17.
MacKie, Rona M., Caroline A. Bray, David Hole, et al.. (2002). Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. The Lancet. 360(9333). 587–591. 167 indexed citations
18.
Bray, Caroline A., et al.. (1998). Enhancing the Power of Record Linkage Involving Low Quality Personal Identifiers: Use of the Best Link Principle and Cause of Death Prior Likelihoods. Computers and Biomedical Research. 31(4). 257–270. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V. Oliver Breakdown of academic impact, for papers by Bridie S. Thompson Breakdown of academic impact, for papers by Giovanni Lo Scocco Breakdown of academic impact, for papers by Amy R. Quillo Breakdown of academic impact, for papers by F. Haddad Breakdown of academic impact, for papers by Martha Matsumoto Breakdown of academic impact, for papers by Ludger Barthelmes Breakdown of academic impact, for papers by Stephen Calabro Breakdown of academic impact, for papers by M Cavaillé‐Coll Breakdown of academic impact, for papers by M. M. Oken
Rankless by CCL
2026